Docmode Health Technologies (NSE:DHTL) YoY EBITDA Growth: 44.58% (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:DHTL Docmode Health Technologies Ltd NSE:DHTL
14 GF Score
Price ₹32.60
View Full Analysis

What is Docmode Health Technologies YoY EBITDA Growth?

Docmode Health Technologies NSE:DHTL 14 YoY EBITDA Growth is 44.58% as of Mar. 2025. GuruFocus rates NSE:DHTL with a GF Score™ of 14/100.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Docmode Health Technologies's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 44.58%.

Docmode Health Technologies's EBITDA per Share for the six months ended in Mar. 2025 was ₹-1.64.

Docmode Health Technologies YoY EBITDA Growth Related Terms

Docmode Health Technologies YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Docmode Health Technologies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Docmode Health Technologies YoY EBITDA Growth Chart

Docmode Health Technologies Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
YoY EBITDA Growth
0.00 115.80 110.34 -50.41 -88.97

Docmode Health Technologies Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial 0.00 0.00 0.00 -74.15 44.58
NSE:DHTL
14GF Score
Docmode Health Technologies Ltd NSE:DHTL
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Docmode Health Technologies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Docmode Health Technologies's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (A: Mar. 2025 )
=(EBITDA per Share (A: Mar. 2025 )-EBITDA per Share (A: Mar. 2024 ))/ | EBITDA per Share (A: Mar. 2024 ) |
=(0.649-5.884)/ | 5.884 |
=-88.97 %

Docmode Health Technologies's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(-1.636--2.952)/ | -2.952 |
=44.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 44.58% mean?
Docmode Health Technologies (NSE:DHTL) has a YoY EBITDA Growth of 44.58% as of Mar. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Docmode Health Technologies and its competitors.
Is Docmode Health Technologies' YoY EBITDA Growth too high?
Docmode Health Technologies' current YoY EBITDA Growth is 44.58%. Overall, Docmode Health Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Docmode Health Technologies' YoY EBITDA Growth compare to VEEV and BTSG?
Docmode Health Technologies' YoY EBITDA Growth of 44.58% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Docmode Health Technologies and its competitors. Docmode Health Technologies's current YoY EBITDA Growth is 44.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Docmode Health Technologies stock overvalued right now?
Docmode Health Technologies (NSE:DHTL) has a current YoY EBITDA Growth of 44.58%. The current YoY EBITDA Growth is 44.58%. Docmode Health Technologies' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Docmode Health Technologies (NSE:DHTL), the current YoY EBITDA Growth is 44.58% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Docmode Health Technologies Business Description

Address Chincholi Bunder Road, 201, Kalpataru Plaza, Rambaug Off, Nadiyawala Colony 2, Malad, Mumbai, MH, IND, 400064
Docmode Health Technologies Ltd is engaged in the business of providing comprehensive & interactive learning programs for healthcare professionals through e-Learning measures and providing online CME (continuous medical education) Certification Courses and designing & conducting surveys, quizzes, questionnaires, etc. for collecting data insights related to the healthcare industry Its business segment is engaged in providing vocational training, DocMode is a platform that provides authoritative, comprehensive, and interactive learning programs for Health Professionals - Doctors, Nurses, Allied and Medical Students - across the world. The company has a new segments namely publishing of Medical books, trading of medical books and journals, conducting customised and inhouse events.
14GF Score

Get the complete analysis for NSE:DHTL

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹32.60
Price